Serum tumor markers in non-small cell lung cancer. A comparative analysis
β Scribed by Mitchell L. Margolis; James B. Hyzy; Larry L. Schenken; Brian S. Schepart
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 486 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Brachytherapy has the ability to deliver a higher tumor dose compared to external beam irradiation, while sparing normal tissue outside the tumor; it is the most effective means of delivering conformal radiation and can be tailored to clinical circumstances, either at open surgery or in an ambulator
Accumulation of mutant p53 protein occurs frequently in human malignancies, including 40-60% of non-small cell lung carcinomas. The implications of such p53 over-expression, usually assessed by immunohistochemical techniques, for the prognosis of lung cancer patients remain undetermined. In this stu